Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levilimab + Methotrexate in Active Rheumatoid Arthritis (SOLAR)
NCT04227366Phase 3Completed
- Sponsor
- BIOCAD
- Start
- Nov 2019
- Primary completion
- Mar 2021
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of levilimab in rheumatoid arthritis (RA), sponsored by BIOCAD. Started Nov 2019; status: completed.
02
Drugs
levilimab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT04227366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04227366.